Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. - Wikidata - awgldk - TriplyDB

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.

http://www.wikidata.org/entity/Q44024571

about

Fluoxetine versus other types of pharmacotherapy for depression Fluoxetine versus other types of pharmacotherapy for depression Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?The development, evolution and philosophy of a clinical research unit.Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression.Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Sex-dependent modulation of treatment response An association study of DRD2 and COMT polymorphisms with novelty seeking and harm avoidance scores, in two independent samples of depressed patients.Pioglitazone adjunctive therapy for moderate-to-severe major depressive disorder: randomized double-blind placebo-controlled trial.Two Chronic Stress Models Based on Movement Restriction in Rats Respond Selectively to Antidepressant Drugs: Aldolase C As a Potential Biomarker Atypical depression: current status and relevance to melancholia.The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder.DSM-IV depression with atypical features: is it valid?Atypical depression: useful concept, but it's time to revise the DSM-IV criteria.Gender differences in antidepressant drug response.Comprehensive review of factors implicated in the heterogeneity of response in depression.Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.Validating the proposed ICD-11 domains.Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression.Trajectories of change in depression severity during treatment with antidepressants.Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression.A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.Orosomucoid influences the response to antidepressants in major depressive disorder.Genetic, developmental and personality correlates of self-mutilation in depressed patients.Influence of sociodemographic and socioeconomic features on treatment outcome in RCTs versus daily psychiatric practice.Low red cell folate levels are associated with poor response to nortriptyline in major depression.Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical application.Elevated C-reactive protein in depression: a predictor of good long-term outcome with antidepressants and poor outcome with psychotherapy.Standardisation framework for the Maudsley staging method for treatment resistance in depression.A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.Temperament, childhood environment and psychopathology as risk factors for avoidant and borderline personality disorders

P2860

Q24201165-C77FA420-1A7F-4E8D-822A-62AD3213C1F2 Q24245764-76307D10-D5D3-4F71-A640-CEB47AE6C41F Q26996411-DD2A6AE4-01A0-4549-966E-13AE249658A3 Q30330436-9476A145-C70A-4C02-ACEE-2018FAD86226 Q33605850-8569F1B5-3251-432B-8BD5-CFDF454CD5F7 Q34461077-470F3EE4-B79A-41DD-8D70-F67FC6060857 Q34482734-53BF5604-EA9B-4694-B17F-8C90E5BC3B96 Q34590507-75D520F4-A543-4C47-BA23-3B55BC54E827 Q35236761-DAB2E05A-C860-4A47-B98A-CDB1F8BAB3BF Q35606447-5E82D128-8B1E-4BFA-8ACE-96FB8CAF3B4E Q36100305-E473E0FE-9FE5-4827-A6AB-3A9FEB9CDEAF Q36287860-8E9A0C9B-D3B0-46F6-B931-0D9AB8361EE9 Q36728898-8D955D63-9443-4416-92FD-E9BD7377DAB5 Q37440898-0C150B22-2307-4F23-97D9-12085379C117 Q37591156-FE220D45-791D-41FF-999B-8B504536FFEC Q37594567-DD9D7107-CD70-4F17-9955-628C6A4F1D1A Q37806757-438E1553-F7ED-4CA9-A652-E8814E1C1E31 Q38003344-CBB9F1EA-A241-4541-A048-15AC31F8B932 Q38214488-5B126260-4461-4E81-A50D-A54177D5FD14 Q39817321-608E3ED8-CC3C-43E0-BBC4-0C3EF76A7C84 Q42630317-911DBC58-46F5-4919-94AB-F070A09FFA79 Q43123878-7A479B8F-0DCA-4CC5-8DC0-D37A94EC5A61 Q43253362-35BFF770-FF98-4AAC-8470-840B3E297F22 Q44024568-E43BD9CB-7ED8-4661-B2CD-FC2501E908AF Q44040260-C2A7AD91-8001-419A-B351-4187A0C6F573 Q44478455-292CA451-9FD3-4E78-87E8-3A71C2FDC357 Q44665523-3310C8C6-88EB-4915-87CE-A59FFAFE0896 Q46036174-9057282A-0516-44AF-B580-4135AEF38B7B Q46942569-0805FA16-7E24-4E1E-994C-CFE4A5845B91 Q48566137-4A649E9A-5F80-4965-BD41-1FD295D22F58 Q50693208-EAF6C43C-4C64-423C-AF42-A1B9A246D12B Q51562107-7E3CE196-B176-46ED-8B49-E56F1B920FFA Q51771552-C1337795-BCFE-43A2-A99B-6E3DE34C8A08 Q53696344-A21C04CF-FDD2-4AFA-BBA2-8223121B9A57 Q55052762-432437BB-DB73-465D-BDF1-CD4C70B70649 Q56267073-49D5C843-189E-4E2A-B33E-5A6CF1E4ECFF

P2860

Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.

http://www.wikidata.org/entity/Q44024571

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@en

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@nl

type

label

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@en

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@nl

prefLabel

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@en

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@nl

P1433

Q44024571-C68C3ADF-C6CF-43B1-9081-AE01201DC42B

P1476

Q44024571-2D4FB1F0-715A-45F2-8826-4949FB9897D4

P2093

Q44024571-0B6A5DFC-7CAA-4DD7-9C48-300007566D2D

Q44024571-27A1568F-5E1B-4EE9-959B-6B25F096B103

Q44024571-30ED0456-D86F-46C2-B6F0-C58288271CB4

Q44024571-47926192-D9BD-4DD9-BAD1-E4A130AFE751

Q44024571-596E2953-EFB5-44BB-855D-409B9C0B8E0B

Q44024571-C6D09A44-7704-4552-BE94-3A4621B158CE

Q44024571-EDCED324-CE86-4240-96DA-87215D3D77C3

P2860

Q44024571-0AD99F05-99F1-47DF-A2B6-35C305556A2D

Q44024571-4322A29F-9A9A-4D23-982C-A93EF296F25E

Q44024571-8790F517-80F6-4F56-82C2-E9DE0A7516B3

Q44024571-9B78A8DF-3721-4715-B85C-148CCEBB6DA4

Q44024571-A24DB489-A273-428C-BA3F-C148938AC1FF

Q44024571-A59D18E8-34C0-4214-A023-923C16B0A913

Q44024571-B1458D6A-1DFE-404A-9E31-6C53B19FE162

Q44024571-B529DDE7-DF12-4422-B4AE-F02406AB393F

Q44024571-B6B04D48-70D1-4260-AFB2-F1C9D326449C

Q44024571-D01DBA70-EF76-4FBF-8191-2527ACD04332

P304

Q44024571-DC15001E-D561-46E5-949D-9C4490B9F606

P31

Q44024571-5843CA4F-21FB-4DD6-A169-41B5A14C8E93

P356

Q44024571-039FD9A1-5DE2-46ED-9BA1-B39F3715D0AF

P433

Q44024571-B885AF56-A436-4F7B-B2FE-2AC6EC106871

P478

Q44024571-A118AFDD-9A05-4B3D-8510-A907D413408F

P577

Q44024571-EBA412BB-8756-4431-BD7C-47B26688917B

P698

Q44024571-EA7FA073-31FF-4647-A6EF-76DC624A5589

P356

J.1440-1614.2001.01026.X

P1433

Australian and New Zealand Journal of Psychiatry

P1476

Patterns and predictors of rem ...... h fluoxetine or nortriptyline.

@en

P2093

Isobel F Stevens

http://www.w3.org/2001/XMLSchema#string

Janice M McKenzie

http://www.w3.org/2001/XMLSchema#string

Patrick F Sullivan

http://www.w3.org/2001/XMLSchema#string

Peter R Joyce

http://www.w3.org/2001/XMLSchema#string

Robyn M Abbott

http://www.w3.org/2001/XMLSchema#string

Roger T Mulder

http://www.w3.org/2001/XMLSchema#string

Suzanne E Luty

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

A new depression scale designed to be sensitive to change

Are the newer antidepressant drugs as effective as established physical treatments? Results from an Australasian clinical panel review.

A psychobiological model of temperament and character.

The definition and operational criteria for treatment outcome of major depressive disorder. A review of the current research literature.

Predictors of drug response in depression.

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research.

Assessment of social adjustment by patient self-report.

Family history of depression in clinic and community samples.

P304

384-391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1440-1614.2001.01026.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12060188

http://www.w3.org/2001/XMLSchema#string